CBS News reports the FDA received reports of two people who died after taking products sold as retatrutide, a weight loss drug still in clinical trials and not approved.
Recap by typeshit. Post by @endocrineclinicatthegym on Instagram.
Some people on weight loss drugs are testing lower doses, hoping for fewer side effects. ThePrint reports on the trend, which these users describe themselves.
Bell raises the question of muscle loss for people losing weight on a GLP-1 and notes it isn't medical advice, pointing viewers to their doctor.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
USA TODAY covers the copycat GLP-1 crackdown, from the Apothecary Pharma recall to an import alert on a Chengdu factory. Novo says it has filed over 130 lawsuits.
Pipes argues that many weight loss and muscle peptides sold online have never had rigorous testing. In her view, that leaves their benefits and risks unknown.
A study of nearly 10,000 matched pairs presented at AAO found no shift in anti-VEGF injections. Other AAO studies looked at AMD and optic neuropathy risk.
Loading…